Effect of lipid types on physicochemical characteristics, stability and antioxidant activity of gamma-oryzanol-loaded lipid nanoparticles

References

• Akihisa T, Yashukawa K, Yamaura M, Ukiya M, Kimura Y, Shimizu N, et al. Triterpene alcohol and sterol ferulates from rice bran and their anti-inflammatory effects. J Agric Food Chem 2000; 48: 2313–2319
   PubMed Web of Science ®Google Scholar
• Alonso MJ. Nanomedicines for overcoming biological barriers. Biomed Pharmacother 2004; 58: 168–172
   PubMed Web of Science ®Google Scholar
• Bouchemal K, Briançon S, Pemer E, Fessi H. Nano-emulsion formulation using spontaneous emulsification: Solvent, oil and surfactant optimisation. Int J Pharm 2004; 280: 241–251
   PubMed Web of Science ®Google Scholar
• Bunjes H, Westesen K, Koch MHJ. Crystallization tendency and polymorphic transitions in triglyceride nanoparticles. Int J Pharm 1996; 129: 159–173
   Web of Science ®Google Scholar
• Cavalli R, Gasco MR, Chetoni P, Burgalassi S, Saettone MF. Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin. Int J Pharm 2002; 238: 241–245
   PubMed Web of Science ®Google Scholar
• Cicero AF, Gaddi A. Rice bran oil and gamma-oryzanol in the treatment of hyperlipoproteinaemias and other conditions. Phytother Res 2001; 15: 277–289
   PubMed Web of Science ®Google Scholar
• Coppini D, Paganizzi P, Santi P, Ghirardini A. Capacità protettiva nei confronti delle radiazioni solari di derivati di origine vegetale. Cosmetic News 2001; 136: 15–20
   Google Scholar
• Freitas C, Müller RH. Correlation between long-term stability of solid lipid nanoparticles (SLN™) and crystallinity of the lipid phase. Eur J Pharm Sci 1999; 47: 125–132
   Google Scholar
• Hiramitsu T, Armstrong D. Preventive effect of antioxidants on lipid peroxidation in the retina. Ophthal Res 1991; 23: 196–203
   PubMed Web of Science ®Google Scholar
• Jenning V, Gohla S. Comparison of wax and glyceride solid lipid nanoparticles (SLN®). Int J Pharm 2000; 196: 219–222
   PubMed Web of Science ®Google Scholar
• Jenning V, Thünhemann AF, Gohla SH. Characterisation of a Novel Solid lipid Nanoparticle carrier system based on binary mixtures of liquid and solid lipids. Int J Pharm 2000; 199: 167–177
   PubMed Web of Science ®Google Scholar
• Jores K, Mehnert W, Drechsler M, Bunjes H, Johann C, Mäder K. Investigations on the structure of solid lipid nanoparticles (SLNs) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionationand transmission electron microscopy. J Contr Rel 2004; 95: 217–227
   PubMed Web of Science ®Google Scholar
• Juliano C, Cossu M, Alamanni MC, Piu L. Antioxidant activity of gamma-oryzanol: Mechanism of action and its effect on oxidative stability of pharmaceutical oils. Int J Pharm 2005; 299: 146–154
   PubMed Web of Science ®Google Scholar
• Kim SJ, Han D, Moon KD, Rhee JS. Measurement of superoxide dismutase-like activity of natural antioxidants. Biosci Biotechnol Biochem 1995; 59: 822–826
   PubMed Web of Science ®Google Scholar
• Lilitchan S, Tangprawat C, Aryusuk K, Krisnangkura S, Chokmoh S, Krisnangkura K. Partial extraction method for the rapid analysis of total lipids and γ-oryzanol contents in rice bran. Food Chem 2008; 106: 752–759
   Web of Science ®Google Scholar
• Lim SJ, Lee MK, Kim CK. Altered chemical and biological activities of all-trans retinoic acid incorporated in solid lipid nanoparticle powders. J Contr Rel 2004; 100: 53–61
   PubMed Web of Science ®Google Scholar
• Mühlen A, Schwarz C, Mehnert W. Solid lipid nanoparticles (SLN) for controlled drug delivery—drug release and release mechanism. Eur J Pharm Biopharm 1998; 45: 149–155
   PubMed Web of Science ®Google Scholar
• Müller RH, Lucks JS. Medication vehicles made of solid lipid particles (solid lipid nanospheres-SLN). Germany. 1996, European Patent 0605497
   Google Scholar
• Müller RH, Mäder K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery—a review of the state of art. Eur J Pharm Biopharm 2000; 50: 161–177
   PubMed Web of Science ®Google Scholar
• Müller RH, Petersen RD, Hommoss A, Pardeike J. Nanostructured lipid carriers (NLC) in cosmetic dermal products. Adv Drug Deliv Rev 2007; 59: 522–30
   PubMed Web of Science ®Google Scholar
• Müller RH, Rühl D, Runge S, Schulze-Forster K, Mehnert W. Cytotoxicity of solid lipid nanoparticles as a function of the lipid matrix and the surfactant. Pharm Res 1997; 14: 458–462
   PubMed Web of Science ®Google Scholar
• Müller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev 2002a; 54: S131–S155
   PubMed Web of Science ®Google Scholar
• Müller RH, Radtke M, Wissing SA. Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm 2002b; 242: 121–128
   PubMed Web of Science ®Google Scholar
• Müller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev 2002c; 54: 131–155
   PubMed Web of Science ®Google Scholar
• Mehnert W, Mäder K. Solid lipid nanoparticles: Production, characterization and applications. Adv Drug. Deliv Rev 2001; 47: 165–196
   PubMed Web of Science ®Google Scholar
• Nanua JN, McGregor JU, Godber JS. Influence of high-oryzanol rice bran oil on the oxidative stability of whole milk powder. J Dairy Sci 2000; 83: 2426–2431
   PubMed Web of Science ®Google Scholar
• Nishiyama N, Kataoka K. Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery. Pharmacol Therapeut 2006; 112: 630–648
   PubMed Web of Science ®Google Scholar
• Rosen H, Abribat T. The rise and rise of drug delivery. Nature Rev Drug Discov 2005; 4: 381–385
   PubMed Web of Science ®Google Scholar
• Rukmini C, Raghuram TC. Nutritional and biochemical aspects of the hypolipidemic action of rice bran oil: A review. J Am Coll Nutrit 1991; 10: 593–601
   PubMed Web of Science ®Google Scholar
• Ruktanonchai U, Limpakdee S, Meejoo S, Sakulkhu U, Bunyapraphatsara N, Junyaprasert V, et al. The Effect of cetyl palmitate crystallinity on physical properties of gamma-oryzanol encapsulated in solid lipid nanoparticles. Nanotechnology 2008; 19: 1–10
   PubMed Web of Science ®Google Scholar
• Saupe A, Gordon KC, Rades T. Structural investigations on naoemulsions, solid lipid nanoparticles and naotstructured lipid carriers by cryo-field emission scanning electron microscopey and Raman spectroscopy. Int J Pharm 2006; 314: 56–62
   PubMed Web of Science ®Google Scholar
• Schöler N, Zimmermann E, Katzfey U, Hahn H, Müller RH, Liesenfeld O. Preserved solid lipid nanoparticles (SLN) at low concentrations do cause neither direct nor indirect cytotoxic effects in peritoneal macrophages. Int J Pharm 2000; 196: 235–239
   PubMed Web of Science ®Google Scholar
• Schubert MA, Harms M, Müller-Goymann CC. Structural investigations on lipid nanoparticles containing high amounts of lecithin. Eur J Pharm Sci 2006; 27: 226–236
   PubMed Web of Science ®Google Scholar
• Solans C, Izquierdo P, Nolla J, Azemar N, Garcia MJ. Nano-emulsions. Curr Opin Colloid Interface Sci 2005; 10: 102–110
   Web of Science ®Google Scholar
• Souto EB, Anselmi C, Centini M, Müller RH. Preparation and characterization of n-dodecyl-ferulate-loaded solid lipid nanoparticles (SLN®). Int J Pharm 2005; 295: 261–268
   PubMed Web of Science ®Google Scholar
• Teeranachaideekul V, Müller RH, Junyaprasert VB. Encapsulation of ascorbyl palmitate in nanostructured lipid carriers (NLC)-Effects of formulation parameters on physicochemical stability. Int J Pharm 2007; 340: 198–206
   PubMed Web of Science ®Google Scholar
• Teeranachaideekul V, Souto EB, Junyaprasert VB, Müller RH. Cetyl palmitate-based NLC for topical delivery of Coenzyme Q10–Development, physicochemical characterization and in vitro release studies. Eur J Pharm Biopharm 2007; 67: 141–148
   PubMed Web of Science ®Google Scholar
• Vivek K, Reddy H, Murthy RSR. Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles. AAPS PharmSciTech 2007; 8: E1–E9
   PubMed Web of Science ®Google Scholar
• Washington C. Stability of lipid emulsions for drug delivery. Adv Drug Deliv Rev 1996; 20: 131–145
   Web of Science ®Google Scholar
• Westesen K, Bunjes H, Koch MHJ. Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading and sustained release potential. J Contr Rel 1997; 48: 223–236
   Web of Science ®Google Scholar
• Wissing SA, Müller RH. Solid lipid nanoparticles as carrier for sunscreens: In vitro release and in vivo skin penetration. J Contr Rel 2002; 81: 225–233
   PubMed Web of Science ®Google Scholar
• Xu Z, Godber JS. Purification and identification of components of oryzanol in rice bran oil. J Agric Food Chem 1999; 47: 2724–2728
   PubMed Web of Science ®Google Scholar
• Xu Z, Hua N, Godber JS. Antioxidant activity of tocopherols, tocotrienols, and γ-oryzanol components from rice bran against cholesterol oxidation accelerated by 2,2′-Azobis(2-methylpropionamidine) dihydrochloride. J Agric Food Chem 2001; 49: 2077–2081
   PubMed Web of Science ®Google Scholar
• Zhang N, Ping Q, Huang G, Xu W, Cheng Y, Han X. Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin. Int J Pharm 2006; 327: 153–159
   PubMed Web of Science ®Google Scholar